Discovery of potent small-molecule inhibitors of lipoprotein(a) formation
Open Access
- 8 May 2024
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 629 (8013) , 945-950
Abstract
Lipoprotein(a) (Lp(a)), an independent, causal cardiovascular risk factor, is a lipoprotein particle that is formed by the interaction of a low-density lipoprotein (LDL) particle and apolipoprotein(a) (apo(a))1,2. Apo(a) first binds to lysine residues of apolipoprotein B-100 (apoB-100) on LDL through the Kringle IV (KIV) 7 and 8 domains, before a disulfide bond forms between apo(a) and apoB-100 to create Lp(a) (refs. 3–7). Here we show that the first step of Lp(a) formation can be inhibited through small-molecule interactions with apo(a) KIV7–8. We identify compounds that bind to apo(a) KIV7–8, and, through chemical optimization and further application of multivalency, we create compounds with subnanomolar potency that inhibit the formation of Lp(a). Oral doses of prototype compounds and a potent, multivalent disruptor, LY3473329 (muvalaplin), reduced the levels of Lp(a) in transgenic mice and in cynomolgus monkeys. Although multivalent molecules bind to the Kringle domains of rat plasminogen and reduce plasmin activity, species-selective differences in plasminogen sequences suggest that inhibitor molecules will reduce the levels of Lp(a), but not those of plasminogen, in humans. These data support the clinical development of LY3473329—which is already in phase 2 studies—as a potent and specific orally administered agent for reducing the levels of Lp(a).Keywords
This publication has 31 references indexed in Scilit:
- Identification of Sequences in Apolipoprotein(a) that Maintain Its Closed Conformation: A Novel Role for Apo(a) Isoform Size in Determining the Efficiency of Covalent Lp(a) FormationBiochemistry, 2004
- Quantitative Evaluation of the Contribution of Weak Lysine-binding Sites Present within Apolipoprotein(a) Kringle IV Types 6–8 to Lipoprotein(a) AssemblyJournal of Biological Chemistry, 2004
- Comparative Analyses of the Lysine Binding Site Properties of Apolipoprotein(a) Kringle IV Types 7 and 10Biochemistry, 2001
- Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and CaucasiansHuman Molecular Genetics, 2001
- Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasiansHuman Molecular Genetics, 1999
- Sequences within Apolipoprotein(a) Kringle IV Types 6−8 Bind Directly to Low-Density Lipoprotein and Mediate Noncovalent Association of Apolipoprotein(a) with Apolipoprotein B-100Biochemistry, 1998
- Inhibitors for the In Vitro Assembly of Lp(a)Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly.Proceedings of the National Academy of Sciences, 1993
- Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.Journal of Biological Chemistry, 1993
- Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a]Biophysical Journal, 1993